Ketil F. Widerberg

Overview

Ketil F. Widerberg is a Norwegian angel investor specializing in early-stage investments in the biotechnology and healthcare sectors. He is the General Manager and CEO of Oslo Cancer Cluster, a leading oncology research and industry cluster dedicated to accelerating the development of new cancer diagnostics and treatments. Under his leadership, the organization has supported numerous startups and facilitated collaborations between academic institutions and commercial partners. With a background in both technology and finance, Widerberg has a strong track record in business development and project management. He holds an MBA from the University of Cambridge and has been instrumental in establishing Oslo Cancer Cluster as a prominent entity in the Norwegian biotech ecosystem. His investment focus includes private equity and venture capital, primarily targeting seed to growth-stage companies within the biotechnology and healthcare industries. Widerberg's strategic approach emphasizes fostering innovation and translating research into viable commercial solutions. His commitment to the sector is evident through his active involvement in various initiatives aimed at enhancing Norway's position in the global biotechnology landscape. His investments are characterized by a hands-on approach, providing not only capital but also strategic guidance to portfolio companies, thereby contributing to their growth and success.

Investment Focus

• Strong management team
• Innovative technology
• Scalable business model
• Clear regulatory pathway

Portfolio Companies